197 related articles for article (PubMed ID: 34111484)
1. A review on the role of TANK-binding kinase 1 signaling in cancer.
Alam M; Hasan GM; Hassan MI
Int J Biol Macromol; 2021 Jul; 183():2364-2375. PubMed ID: 34111484
[TBL] [Abstract][Full Text] [Related]
2. TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells.
Scuderi SA; Lanza M; Casili G; Esposito F; Colarossi C; Giuffrida D; Irene P; Cuzzocrea S; Esposito E; Campolo M
Oncol Res; 2021 Sep; 28(7):779-790. PubMed ID: 33741083
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug development: Challenges and opportunities.
Alam M; Ansari MM; Noor S; Mohammad T; Hasan GM; Kazim SN; Hassan MI
Int J Biol Macromol; 2022 May; 207():1022-1037. PubMed ID: 35358582
[TBL] [Abstract][Full Text] [Related]
4. BX795, a TBK1 inhibitor, exhibits antitumor activity in human oral squamous cell carcinoma through apoptosis induction and mitotic phase arrest.
Bai LY; Chiu CF; Kapuriya NP; Shieh TM; Tsai YC; Wu CY; Sargeant AM; Weng JR
Eur J Pharmacol; 2015 Dec; 769():287-96. PubMed ID: 26607461
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TBK1 attenuates radiation-induced epithelial-mesenchymal transition of A549 human lung cancer cells via activation of GSK-3β and repression of ZEB1.
Liu W; Huang YJ; Liu C; Yang YY; Liu H; Cui JG; Cheng Y; Gao F; Cai JM; Li BL
Lab Invest; 2014 Apr; 94(4):362-70. PubMed ID: 24468793
[TBL] [Abstract][Full Text] [Related]
6. Targeting TANK-binding kinase 1 (TBK1) in cancer.
Revach OY; Liu S; Jenkins RW
Expert Opin Ther Targets; 2020 Nov; 24(11):1065-1078. PubMed ID: 32962465
[TBL] [Abstract][Full Text] [Related]
7. TBK1 inhibitors: a review of patent literature (2011 - 2014).
Yu T; Yang Y; Yin DQ; Hong S; Son YJ; Kim JH; Cho JY
Expert Opin Ther Pat; 2015; 25(12):1385-96. PubMed ID: 26293650
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies.
Hasan M; Yan N
Pharmacol Res; 2016 Sep; 111():336-342. PubMed ID: 27353409
[TBL] [Abstract][Full Text] [Related]
9. Blocking TBK1 alleviated radiation-induced pulmonary fibrosis and epithelial-mesenchymal transition through Akt-Erk inactivation.
Qu H; Liu L; Liu Z; Qin H; Liao Z; Xia P; Yang Y; Li B; Gao F; Cai J
Exp Mol Med; 2019 Apr; 51(4):1-17. PubMed ID: 30988282
[TBL] [Abstract][Full Text] [Related]
10. TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.
Cooper JM; Ou YH; McMillan EA; Vaden RM; Zaman A; Bodemann BO; Makkar G; Posner BA; White MA
Cancer Res; 2017 Sep; 77(18):5077-5094. PubMed ID: 28716898
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in small molecule TBK1 inhibitors: a patent review (2015- 2020).
Thomson DW; Bergamini G
Expert Opin Ther Pat; 2021 Sep; 31(9):785-794. PubMed ID: 33724136
[No Abstract] [Full Text] [Related]
12. The role of TBK1 in cancer pathogenesis and anticancer immunity.
Runde AP; Mack R; S J PB; Zhang J
J Exp Clin Cancer Res; 2022 Apr; 41(1):135. PubMed ID: 35395857
[TBL] [Abstract][Full Text] [Related]
13. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
14. TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery.
Xiang S; Song S; Tang H; Smaill JB; Wang A; Xie H; Lu X
Drug Discov Today; 2021 Oct; 26(10):2445-2455. PubMed ID: 34051368
[TBL] [Abstract][Full Text] [Related]
15. Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation.
Yang S; Imamura Y; Jenkins RW; Cañadas I; Kitajima S; Aref A; Brannon A; Oki E; Castoreno A; Zhu Z; Thai T; Reibel J; Qian Z; Ogino S; Wong KK; Baba H; Kimmelman AC; Pasca Di Magliano M; Barbie DA
Cancer Immunol Res; 2016 Jun; 4(6):520-30. PubMed ID: 27068336
[TBL] [Abstract][Full Text] [Related]
16. TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes.
Möser CV; Stephan H; Altenrath K; Kynast KL; Russe OQ; Olbrich K; Geisslinger G; Niederberger E
J Neuroinflammation; 2015 May; 12():100. PubMed ID: 25997745
[TBL] [Abstract][Full Text] [Related]
17. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
18. Recent insights into the complexity of Tank-binding kinase 1 signaling networks: the emerging role of cellular localization in the activation and substrate specificity of TBK1.
Helgason E; Phung QT; Dueber EC
FEBS Lett; 2013 Apr; 587(8):1230-7. PubMed ID: 23395801
[TBL] [Abstract][Full Text] [Related]
19. Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in Cancer.
Jairajpuri DS; Mohammad T; Hussain A; Alajmi MF; Yadav DK; Hassan MI
Discov Med; 2024 Jan; 36(180):129-139. PubMed ID: 38273753
[TBL] [Abstract][Full Text] [Related]
20. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation.
Ou YH; Torres M; Ram R; Formstecher E; Roland C; Cheng T; Brekken R; Wurz R; Tasker A; Polverino T; Tan SL; White MA
Mol Cell; 2011 Feb; 41(4):458-70. PubMed ID: 21329883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
